ICL Israel Chemicals Ltd (ICL)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NYSE
Market Cap: $6.03B
Last updated: Nov 17, 2026 at 11:06 AM ET
ICL Israel Chemicals Ltd (ICL) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, ICL Israel Chemicals reported EPS of $0.10, below the $0.11 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ICL's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
ICL Earnings Call
The latest ICL earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, ICL beat 25, missed 6 and matched 9. Revenue for the quarter ended Sep 30, 2026 was $1.91B, up 3.2% from $1.85B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.10 | $0.11 | $0.08 - $0.11 | -9.09% | Miss | 0.0% | 4 | 0 up, 3 down | Nov 10, 2026 | $1.91B |
| Jun 30, 2026 | $0.12 | $0.11 | $0.10 - $0.12 | +9.09% | Beat | +33.3% | 4 | 4 up, 0 down | Aug 5, 2026 | $2.13B |
| Dec 31, 2025 | $0.09 | $0.09 | $0.09 - $0.10 | 0.00% | In line | +12.5% | 3 | 0 up, 1 down | Feb 18, 2026 | $1.70B |
| Sep 30, 2025 | $0.10 | $0.10 | $0.09 - $0.11 | 0.00% | In line | -9.1% | 4 | 0 up, 2 down | Nov 12, 2025 | $1.85B |
| Jun 30, 2025 | $0.09 | $0.08 | $0.08 - $0.09 | +12.50% | Beat | -10.0% | 2 | 1 up, 1 down | Aug 6, 2025 | $1.83B |
| Mar 31, 2025 | $0.09 | $0.08 | $0.08 - $0.11 | +12.50% | Beat | 0.0% | 4 | 1 up, 2 down | May 19, 2025 | $1.77B |
| Dec 31, 2024 | $0.08 | $0.09 | $0.05 - $0.11 | -11.11% | Miss | -20.0% | 5 | 2 up, 2 down | Feb 26, 2025 | $1.60B |
| Sep 30, 2024 | $0.11 | $0.08 | $0.07 - $0.10 | +37.50% | Beat | 0.0% | 5 | 0 up, 0 down | Nov 11, 2024 | $1.75B |
| Jun 30, 2024 | $0.10 | $0.09 | $0.08 - $0.09 | +11.11% | Beat | -23.1% | 5 | 1 up, 0 down | Aug 14, 2024 | $1.75B |
| Mar 31, 2024 | $0.09 | $0.09 | $0.08 - $0.10 | 0.00% | In line | -60.9% | 5 | 1 up, 0 down | May 9, 2024 | $1.74B |
| Dec 31, 2023 | $0.10 | $0.08 | $0.06 - $0.09 | +25.00% | Beat | -64.3% | 4 | 0 up, 0 down | Feb 28, 2024 | $1.69B |
| Sep 30, 2023 | $0.11 | $0.09 | $0.07 - $0.11 | +22.22% | Beat | -77.6% | 4 | 0 up, 1 down | Nov 8, 2023 | $1.86B |
| Jun 30, 2023 | $0.13 | $0.13 | $0.11 - $0.14 | 0.00% | In line | -77.6% | 4 | 1 up, 0 down | Aug 9, 2023 | $1.87B |
| Mar 31, 2023 | $0.23 | $0.21 | $0.17 - $0.27 | +9.52% | Beat | -53.1% | 4 | 0 up, 0 down | May 10, 2023 | $2.10B |
| Dec 31, 2022 | $0.28 | $0.29 | $0.26 - $0.37 | -3.45% | Miss | +7.7% | 5 | 0 up, 0 down | Feb 15, 2023 | $2.09B |
| Sep 30, 2022 | $0.49 | $0.45 | N/A | +8.89% | Beat | +188.2% | N/A | N/A | Nov 9, 2022 | $2.52B |
| Jun 30, 2022 | $0.58 | $0.53 | N/A | +9.43% | Beat | +427.3% | N/A | N/A | Jul 27, 2022 | $2.88B |
| Mar 31, 2022 | $0.49 | $0.29 | N/A | +68.97% | Beat | +345.5% | N/A | N/A | May 11, 2022 | $2.52B |
| Dec 31, 2021 | $0.26 | $0.16 | $0.10 - $0.19 | +62.50% | Beat | +420.0% | 4 | 0 up, 0 down | Feb 9, 2022 | $2.04B |
| Sep 30, 2021 | $0.17 | $0.14 | $0.10 - $0.16 | +21.43% | Beat | +240.0% | 5 | 0 up, 0 down | Nov 4, 2021 | $1.79B |
| Jun 30, 2021 | $0.11 | $0.09 | $0.06 - $0.11 | +22.22% | Beat | +83.3% | 4 | N/A | Jul 28, 2021 | $1.62B |
| Mar 31, 2021 | $0.11 | $0.06 | N/A | +83.33% | Beat | +120.0% | N/A | N/A | May 6, 2021 | $1.51B |
| Dec 31, 2020 | $0.05 | $0.04 | N/A | +25.00% | Beat | +25.0% | N/A | N/A | Feb 11, 2021 | $1.32B |
| Sep 30, 2020 | $0.05 | $0.03 | N/A | +66.67% | Beat | -50.0% | N/A | N/A | Nov 12, 2020 | $1.20B |
| Jun 30, 2020 | $0.06 | $0.05 | $0.04 - $0.05 | +20.00% | Beat | -50.0% | 5 | N/A | Jul 29, 2020 | $1.20B |
| Mar 31, 2020 | $0.05 | $0.05 | $0.03 - $0.07 | 0.00% | In line | -58.3% | 5 | N/A | May 12, 2020 | $1.32B |
| Dec 31, 2019 | $0.04 | $0.04 | $0.03 - $0.06 | 0.00% | In line | -60.0% | 5 | N/A | Feb 13, 2020 | $1.11B |
| Sep 30, 2019 | $0.10 | $0.09 | $0.09 - $0.10 | +11.11% | Beat | 0.0% | 4 | N/A | Nov 7, 2019 | $1.32B |
| Jun 30, 2019 | $0.12 | $0.11 | $0.10 - $0.12 | +9.09% | Beat | +33.3% | 4 | N/A | Jul 31, 2019 | $1.43B |
| Mar 31, 2019 | $0.12 | $0.10 | $0.09 - $0.11 | +20.00% | Beat | +50.0% | 4 | N/A | May 7, 2019 | $1.42B |
| Dec 31, 2018 | $0.10 | $0.09 | $0.09 - $0.10 | +11.11% | Beat | -9.1% | 3 | N/A | Feb 6, 2019 | $1.41B |
| Sep 30, 2018 | $0.10 | $0.10 | $0.08 - $0.12 | 0.00% | In line | +11.1% | 3 | N/A | Nov 1, 2018 | $1.37B |
| Jun 30, 2018 | $0.09 | $0.07 | $0.07 - $0.09 | +28.57% | Beat | +80.0% | 3 | N/A | Aug 1, 2018 | $1.37B |
| Mar 31, 2018 | $0.08 | $0.08 | $0.07 - $0.09 | 0.00% | In line | +60.0% | 2 | N/A | May 10, 2018 | $1.40B |
| Dec 31, 2017 | $0.11 | $0.08 | $0.07 - $0.09 | +37.50% | Beat | +22.2% | 3 | N/A | Feb 14, 2018 | $1.36B |
| Sep 30, 2017 | $0.09 | $0.08 | $0.08 - $0.08 | +12.50% | Beat | 0.0% | 3 | N/A | Nov 8, 2017 | $1.44B |
| Jun 30, 2017 | $0.05 | $0.07 | $0.05 - $0.08 | -28.57% | Miss | -50.0% | 4 | N/A | Aug 3, 2017 | $1.32B |
| Mar 31, 2017 | $0.05 | $0.06 | N/A | -16.67% | Miss | -28.6% | N/A | N/A | May 10, 2017 | $1.29B |
| Dec 31, 2016 | $0.09 | $0.09 | N/A | 0.00% | In line | -35.7% | N/A | N/A | Feb 15, 2017 | $1.34B |
| Sep 30, 2016 | $0.09 | $0.10 | N/A | -10.00% | Miss | -25.0% | N/A | N/A | Nov 23, 2016 | $1.38B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.37, within 4 cents of the year before. It was $0.35 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.37 | N/A |
| Dec 31, 2024 | $0.38 | -33.3% |
| Dec 31, 2023 | $0.57 | -69.0% |
| Dec 31, 2022 | $1.84 | +183.1% |
| Dec 31, 2021 | $0.65 | +209.5% |
| Dec 31, 2020 | $0.21 | -44.7% |
| Dec 31, 2019 | $0.38 | N/A |
| Dec 31, 2018 | $0.37 | +23.3% |
| Dec 31, 2017 | $0.30 | -14.3% |
| Dec 31, 2016 | $0.35 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,200 words across 6 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 4,152 | 6 | |
| 2026Q2 | Jun 30, 2026 | 5,310 | 6 | |
| 2026Q1 | Mar 31, 2026 | 3,927 | 6 | |
| 2025Q4 | Dec 31, 2025 | 6,256 | 7 | |
| 2025Q3 | Sep 30, 2025 | 7,586 | 7 | |
| 2025Q2 | Jun 30, 2025 | 5,596 | 7 | |
| 2025Q1 | Mar 31, 2025 | 4,036 | 5 | |
| 2024Q4 | Dec 31, 2024 | 6,814 | 9 |
2026Q3 Earnings Call
Opening remarks
Peggy Reilly Tharp Vice President of Global Investor Relations Hello, everyone. I'm Peggy Reilly Tharp, Vice President of Global Investor Relations for ICL Group. I'd like to welcome you, and thank you for joining us today for our earnings conference call. This event is being webcast live on our website at icl-group.com, and there will be a replay available a few hours after the live call and a transcript will be available shortly thereafter. Earlier today, we filed our reports and our presentations with the securities authorities and the stock exchanges in both Israel and the United States. Those reports, as well as the press release and our presentation, are available on our website. Please be sure to review the disclaimer on Slide 2 of the presentation. Our comments today will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are not guarantees of future performance. The company undertakes no obligation to update any information discussed on this call at any time. With that, we will begin with the presentation by our CEO, Mr. Elad Aharonson, followed by Mr. Asaf Alperovitz, our CFO. After the presentation, we will open the line for the Q&A session. I would now like to turn the call over to Elad.
Elad Aharonson CEO Thank you, Peggy, and welcome, everyone, to review our third quarter 2026 earnings. On Slide 3, you can see some highlights. We delivered another quarter of growth in key results, with sales of $1.9 billion, which were up 3% year-over-year. Adjusted EBITDA of $402 million increased 1% versus the prior year. This growth was achieved despite record-high raw material prices and elevated freight and logistics costs. During the quarter, we successfully implemented price increases across key end markets and targeted high-margin product mix. On an annual basis, gross margin improved 30 basis points in the third quarter to 32.9%, our highest rate since the fourth quarter of 2024. For the third quarter, we reported a 2% improvement in adjusted net income of $126 million, which translates to adjusted earnings per share of $0.10. Operating cash flow was $256 million in the third quarter, while free cash flow was $66 million, as we delivered solid underlying cash generation. If you turn to Slide 4, I would like to share some business highlights for each of our current segments. For Industrial Products, a very strong quarter was driven by higher bromine prices and improving demand in key end markets. In Potash, higher prices partially offset the strong currency headwinds and higher energy and logistics costs we experienced in the third quarter.
Frequently Asked Questions About ICL
Did ICL beat earnings estimates last quarter?
No. ICL Israel Chemicals reported EPS of $0.10 for the quarter ended Sep 30, 2026, below the $0.11 estimate by 9.09%.
What EPS do analysts expect from ICL next quarter?
The consensus EPS estimate for ICL Israel Chemicals for the quarter ending Dec 31, 2026 is $0.09 from 3 analysts, with estimates from $0.09 to $0.09.
How often does ICL beat earnings estimates?
ICL Israel Chemicals beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +6.42%.
ICL pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors